Volpara Health Technologies shares are on a tear - thanks to gains in the US, and an attendant jump in revenue.

The Wellington-based, Australian-listed maker of breast-screening software edged ahead of its guidance when it delivered its quarterly cashflow report to the ASX this morning - and predicted strong gains ahead.

Volpara's stock has performed solidly since its April 2016 IPO at 50Ac (see chart below).

But it has really taken off over the past few weeks, spiking to an all-time high of A$1.94 on several pieces of positive news.


The first came on March 28, when the US Food


Grass greener across the ditch